eplex BCID-FP Controls
Fungemia such as candidemia are serious, often life-threatening infections, where early detection and appropriate therapy are critical to reduce mortality. MMQCI’s eplex BCID-FP Control M320v1.1 and eplex BCID-FP Negative help to reliably identify potential pathogenic fungal organisms in positive blood culture to ensure correct diagnosis.
eplex BCID-GP Controls
Our eplex BCID-GP Control M323v1.1 and eplex BCID-GP Negative monitor the qualitative detection of gram-positive pathogens and resistance genes to help with the diagnosis and treatments of severe bacterial infections such as Staph infections that can lead to critical conditions such as sepsis.
eplex BCID-GN Control
E.coli and other blood culture gram-negative bacteria can cause severe systemic infections. Our eplex BCID-GN Control M326 and eplex BCID-GN Negative can facilitate the correct identification of gram-negative bacteria and resistance markers, to help guide clinicians to determine timely and effective antibiotic therapy.
FilmArray® BCID2
The FilmArray® BCID2 Positive Control Panel M416 provides external quality control coverage for all 43 targets detected by the BIOFIRE® BCID2 Panel, including 26 bacterial targets, 7 yeast targets, and 10 antimicrobial resistance genes. With only one positive control, laboratories can monitor the performance of the full BCID2 target menu.
QIAstat GPF
Product in Development
QIAstat GN
Product in Development
LIAISON PLEX Yeast Control Panel
Product in Development
LIAISON PLEX GN Control Panel
Product in Development
LIAISON PLEX GP Control Panel
Product in Development